Literature DB >> 28723766

Lady with wings: a case report of giant neurofibromatosis type I.

Suraj Maharjan1, Xiucun Li, Jianli Cui, Yang Liu, Laijin Lu.   

Abstract

RATIONALE: Neurofibromatosis type I (NF-I) accounts for approximately 90% of neurofibromatosis. NF-I is an autosomal dominant genetic disease which results from the gene mutation of NF-I situated in chromosome 17q11.2. PATIENT CONCERNS: A 32-year-old lady presented with a giant wing like structure on her back which started growing from her childhood. DIAGNOSIS: A diagnosis of NF-I was confirmed as she presented with multiple cutaneous nodules, multiple café-au-lait macules of different sizes, scoliosis deformity, and positive family history of neurofibroma.
INTERVENTIONS: Surgical excision of tumor and multiple Z plasty reconstruction of the back was carried out. OUTCOMES: The excised neurofibroma weighed 6.7 kg containing thickened nerves, nerve roots, and circuitous vessels. The histopathological report confirmed plexiform and diffuse type cutaneous neurofibroma without any malignant transformation. Surgical excision and reconstruction with regular follow-up is an excellent choice of treatment for such a giant neurofibroma as in this case. LESSONS: NF-I is a genetic disease which could present as a giant cutaneous neurofibroma. One of the treatment options for giant neurofibromas causing deformity and physical disability is by surgical excision and histopathological examination with regular follow-up for NF-I recurrence.

Entities:  

Mesh:

Year:  2017        PMID: 28723766      PMCID: PMC5521906          DOI: 10.1097/MD.0000000000007523

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Neurofibromatosis type I (NF-I) is an autosomal dominant genetic disease which results from the gene mutation of NF-I situated in chromosome 17q11.2.[ NF-I accounts for approximately 90% cases of neurofibromatosis.[ Although, there are many reports on giant neurofibromas,[ only few of them are complex neurofibromas consisting of plexiform and diffuse cutaneous neurofibromas. We report a case of giant wing like neurofibroma at the back of a 32-year-old lady.

Case report

An approval from the ethics committee of the first Hospital of Jilin University was obtained for this case report study. A 32-year-old lady weighing 37.5 kg and 147 cm tall presented with overhanging wing like mass on her back with scoliosis deformity. Initially the mass was a small pea size nodule over the right anterior chest wall which gradually increased in size since early childhood and extended to the back with wings like presentation by adolescence. She has a positive family history of neurofibromatosis. On examination, the mass measured 60 cm × 41 cm with surface ulceration at the distal end. Multiple café-au-lait macules of different sizes and hard cutaneous nodules were present at the back, axilla, and thoracoabdominal regions (Fig. 1A–C). She did not give history of past medical or surgical intervention. All the routine laboratory tests were normal. Thoraco-abdominal plain radiography antero-posterior view showed scoliosis deformity of cervical and thoracic spine.[ Magnetic resonance imaging revealed “S” shaped curve with an angular deformity at thoracic vertebrae involving T1–T7. No other abnormalities were seen in magnetic resonance imaging regarding centrum, intervertebral disk, and spinal cord (Fig. 2). The patient did not undergo genetic testing. The patient was diagnosed NF-I (plexiform type) from her history and clinical examination.
Figure 1

Clinical presentation of the patient. (A, B) Giant wing shaped tumor; (B, C) café-au-lait spots and cutaneous nodules; (D) thickened subcutaneous nerves and nerve roots; (E) excised tumor; and (F) follow-up after 15 months.

Figure 2

X-ray and magnetic resonance imaging (MRI) spine, and histopathological findings. (A) Anteroposterior thoraco-abdominal X-ray; (B, C) the results of MRI sagittal sections: cervical and thoracic spine scoliosis deformity, and neurofibroma at the back. (D, E) Histopathological findings: cellular matrix containing fibroblasts, Schwann cells, and collagen (hematoxylin and eosin 20× and 40× magnification).

Clinical presentation of the patient. (A, B) Giant wing shaped tumor; (B, C) café-au-lait spots and cutaneous nodules; (D) thickened subcutaneous nerves and nerve roots; (E) excised tumor; and (F) follow-up after 15 months. X-ray and magnetic resonance imaging (MRI) spine, and histopathological findings. (A) Anteroposterior thoraco-abdominal X-ray; (B, C) the results of MRI sagittal sections: cervical and thoracic spine scoliosis deformity, and neurofibroma at the back. (D, E) Histopathological findings: cellular matrix containing fibroblasts, Schwann cells, and collagen (hematoxylin and eosin 20× and 40× magnification). The tumor excision and reconstruction was done with multiple Z-plasty. The tumor weighed 6.7 kg, containing thickened subcutaneous nerves and nerve roots, large and diffuse circuitous vessels (Fig. 1D, E). Histopathological exam reported giant neurofibroma with components of plexiform and diffuse cutaneous neurofibromas (Fig. 2D, E). At 15 months follow-up, there was complete healing of reconstructed skin at the back with no signs of tumor regrowth. The patient was extremely satisfied with the outcome and ability to carry out her daily activities (Fig. 1F).

Discussion

Its diagnosis is based on 2 or more of the diagnostic criteria mentioned in Table 1.[ Our patient met the criteria for the diagnosis of NF-I due to the presence of the following: positive family history of her mother, brother, and son, all diagnosed with NF-I; 6 or more café-au-lait spots in the axilla, back, and thoracoabdominal regions; and multiple cutaneous nodules (Fig. 1A–C).
Table 1

The diagnostic criteria for NF-I[.

The diagnostic criteria for NF-I[. The initial manifestation of NF-I is usually café-au-lait spots.[ Nodular neurofibromas can appear in peripheral nerves at any regions of the body and have the capability of growing into a large size,[ whereas, diffuse cutaneous neurofibromas are more common in adults, ranging from several to many thousands.[ The neurofibromas over the trunk is one of the common manifestations which accounts for 64% followed by upper extremity (54%), head and neck (48%), and lower extremity (31%).[ Although, plexiform neurofibromas (PNFs) are analogous to cutaneous neurofibromas, they comprise mainly of extracellular matrix and vessels.[ They usually are derived from dorsal spinal roots, large nerve trunks, or sympathetic chains.[ PNF accounts for approximately 30% of patients with NF-I, of which most of them are frequently in the cranio maxillofacial region.[ Diffuse PNF of the faciocervical region rarely appears after the 1st year of life, and diffuse PNF of other parts of the body rarely develops after adolescence.[ Furthermore, in approximately 2% to 16% of patients, the nodular and PNFs can transform to malignant peripheral nerve sheath tumors.[ The tumor in our patient gradually increased in size from chlidhood to adulthood. The weight of tumor excised was 6.7 kg but the histopathological examination did not show any malignant transformation. With regard to the treatment of these giant tumors, surgical treatment still remains the mainstream, aiming at improving functional and aesthetic effect.[ However, we agree that the most difficult challenge for this surgery is the variation of anatomy and unclear tumor margin. In addition, the tumor contains thickened cord of nerves along with abundant abnormal vessels; therefore, excessive hemorrhage during the operation is also a brainteaser. Furthermore, if the nerve roots of neurofibromas are from major nerves, surgical resection may result in functional impairment. Therefore, the surgeon must cautiously design a detailed preoperative treatment strategy. For the giant neurofibroma of the back of in our patient, resection of the tumor was successfully performed and the defect was covered using local skin flaps with multiple Z-plasty reconstruction. Postoperative wound infection and skin necrosis was not observed. Furthermore, our patient also presented with scoliosis deformity of cervical and thoracic spine,[ but she refused spinal orthopedic consultation as she had no neurological symptoms and signs. Follow-up at 15 months revealed no sign of tumor recurrence with satisfactory healing. Moreover, shedding the heavy weight from her back has benefited the patient physically as well as psychologically. However, we recommend regular long-term follow-up to assess tumor recurrence. We conclude that surgical excision and reconstruction with regular follow-up is an excellent treatment of choice for giant neurofibromas as in our case.
  11 in total

1.  Surgical treatment of a giant neurofibroma.

Authors:  Xiao-Bing Cheng; De-Lin Lei; Yun-Peng Li; Lei Tian; Yan-Pu Liu; Xing-Hua Feng; Xiao-Guang Hu; Mo-Yi Sun; Qin Ma; Tian-Qiu Mao; Bao-Lin Liu; Yi-Min Zhao; Zhi-Hong Feng; Li-Xian Xu; Hui Zhang; Tie-Cheng Zhang; Rui Liu; Lei Shen
Journal:  J Craniofac Surg       Date:  2011-11       Impact factor: 1.046

Review 2.  Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1.

Authors:  R M Reynolds; G G P Browning; I Nawroz; I W Campbell
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 3.  Clinical manifestations and management of neurofibromatosis type 1.

Authors:  James H Tonsgard
Journal:  Semin Pediatr Neurol       Date:  2006-03       Impact factor: 1.636

4.  Surgical management of giant neurofibroma in soft tissue: a single-center retrospective analysis.

Authors:  Si-Ming Yuan; Lei Cui; Yao Guo; Jun Wang; Xin-Bao Hu; Hui-Qing Jiang; Zhi-Jian Hong
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  Neurofibromatosis type I: clinical and imaging features of Von Recklinghausen's disease.

Authors:  Brooke L Gajeski; Norman W Kettner; Eric E Awwad; Ron J Boesch
Journal:  J Manipulative Physiol Ther       Date:  2003-02       Impact factor: 1.437

6.  Giant neurofibroma in the right lower limb of a 26-year-old woman: report of a case.

Authors:  Jianda Zhou; Ming Li; Chengqun Luo; Quanyong He; Zhaoqi Yin; Hao Peng; Zizi Chen; Jiye Chen; Shi Zhong; Xie Huiqing
Journal:  Int Surg       Date:  2012 Jan-Mar

Review 7.  Scoliosis associated with neurofibromatosis.

Authors:  Alvin H Crawford; Jose Herrera-Soto
Journal:  Orthop Clin North Am       Date:  2007-10       Impact factor: 2.472

8.  Electrosurgical excision technique for the treatment of multiple cutaneous lesions in neurofibromatosis type I.

Authors:  Steven M Levine; Elie Levine; Peter J Taub; Hubert Weinberg
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-05-25       Impact factor: 2.740

Review 9.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

10.  Plexiform Neurofibroma: A Case Report.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; James W Patterson; Ilko Bakardzhiev; Uwe Wollina; Claudio Tana
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more
  1 in total

1.  Neurofibromatosis Type 1 with Massive Ventricular Polyposis: First Report in the Medical Literature.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Uwe Wollina; Torello Lotti; Georgi Konstantinov Maximov; Ilia Lozev
Journal:  Open Access Maced J Med Sci       Date:  2018-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.